Mutations in carboxy-terminal part of E2 including PKR/eIF2alpha phosphorylation homology domain and interferon sensitivity determining region of nonstructural 5A of hepatitis C virus 1b: their correlation with response to interferon monotherapy and
about
Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine DesignMutations in E2-PePHD, NS5A-PKRBD, NS5A-ISDR, and NS5A-V3 of Hepatitis C Virus Genotype 1 and Their Relationships to Pegylated Interferon-Ribavirin Treatment ResponsesResponse to combination therapy of HCV 3a infected Pakistani patients and the role of NS5A protein.A novel approach to identify candidate prognostic factors for hepatitis C treatment response integrating clinical and viral genetic data.Hepatitis C virus: How genetic variability affects pathobiology of disease.Role of different regions of the hepatitis C virus genome in the therapeutic response to interferon-based treatment.The role of HCV proteins on treatment outcomes.Sequencing of E2 and NS5A regions of HCV genotype 3a in Brazilian patients with chronic hepatitis.Analysis of the PKR-eIF2alpha phosphorylation homology domain (PePHD) of hepatitis C virus genotype 1 in HIV-coinfected patients by ultra-deep pyrosequencing and its relationship to responses to pegylated interferon-ribavirin treatment.Viral kinetic of HCV genotype-4 during pegylated interferon alpha 2a: ribavirin therapy.Hepatitis C virus amino acid sequence diversity correlates with the outcome of combined interferon/ribavirin therapy in Chinese patients with chronic hepatitis C.Mutations in two PKR-binding domains in chronic hepatitis C of genotype 3a and correlation with viral loads and interferon responsiveness.
P2860
Q26801759-9AF01616-0050-48FC-A5E1-DF0AE3474465Q27486410-4EEA5AC1-E3AB-4038-AED5-DB12FA31DDDCQ35054206-6D2843F9-5414-483A-8D36-C14D2F857349Q35579175-09DCF520-9F63-4ACA-926C-B6402747B322Q37825652-0FD71B58-5B74-4DE6-9B53-6F02926E6D87Q38121422-DBC94CB1-C931-4D5F-A2F5-C85D122FB232Q38668968-1CD5F34F-5B98-439D-9F8F-8B4EB03EE739Q39208854-8FA21B6B-04FA-4E9B-BFFA-7577E30CB695Q42977060-2AC230F6-9A33-436A-8A69-42CDA630C0AEQ42978463-5AE8E98F-9B6F-4B62-863D-628CBE39A787Q42978470-F3314097-F112-4A87-A442-EA2E3057E0A5Q43039682-4E299551-A137-4ABF-8D46-B88C62B642C2
P2860
Mutations in carboxy-terminal part of E2 including PKR/eIF2alpha phosphorylation homology domain and interferon sensitivity determining region of nonstructural 5A of hepatitis C virus 1b: their correlation with response to interferon monotherapy and
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Mutations in carboxy-terminal ...... to interferon monotherapy and
@ast
Mutations in carboxy-terminal ...... to interferon monotherapy and
@en
type
label
Mutations in carboxy-terminal ...... to interferon monotherapy and
@ast
Mutations in carboxy-terminal ...... to interferon monotherapy and
@en
prefLabel
Mutations in carboxy-terminal ...... to interferon monotherapy and
@ast
Mutations in carboxy-terminal ...... to interferon monotherapy and
@en
P2093
P2860
P356
P1476
Mutations in carboxy-terminal ...... to interferon monotherapy and
@en
P2093
Hidemi Goto
Kazuhiko Hayashi
Kentaro Yoshioka
Masatoshi Ishigami
Motoyoshi Yano
Naoto Kawabe
Takashi Honda
Yoshiaki Katano
P2860
P304
P356
10.3748/WJG.V12.I23.3722
P407
P577
2006-06-01T00:00:00Z